)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Astellas Pharma (4503) investor relations material
Astellas Pharma Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary30 Jul, 2025
Executive summary
Q1 FY2025 delivered exceptional revenue and profit growth, surpassing expectations, driven by strategic brands, new product launches, and cost optimization initiatives.
Underlying revenue grew 12% year-on-year excluding FX impact, with strategic brands achieving 57% underlying growth.
Core operating profit margin rose to 28.1%, up 9.5 percentage points year-on-year.
Pipeline advanced with key proof-of-concept milestones and exclusive license agreements, including for ASP5460/Claudin 18.2 therapies.
All major regions reported revenue growth, with China up 57.8% year-on-year.
Financial highlights
Revenue reached ¥505.8 billion, up 6.9% year-on-year; core operating profit rose to ¥142.3 billion, up 61.1%.
Net profit grew 82% year-on-year to ¥68.4 billion; basic EPS increased 82% to ¥38.22.
SG&A expenses fell 4.8% to ¥197.0 billion, with the SG&A ratio improving by 4.2ppt to 26.5%.
R&D expenses decreased 17.4% to ¥71.7 billion, with the R&D ratio at 14.2%.
FX headwinds reduced revenue by ¥26.1 billion and core OP by ¥7.1 billion in Q1.
Outlook and guidance
Positive growth momentum is expected to continue throughout FY2025, with strategic brands driving revenue and profit.
Full-year guidance will be reviewed in Q2, considering strong Q1 performance.
R&D investments to expand from Q2 onwards, aligned with further proof-of-concept achievements.
FX rate assumptions for FY2025: 140 yen/USD, 160 yen/EUR; actual Q1 rates were 145 yen/USD, 164 yen/EUR.
Estimated FX sensitivity: 1 yen depreciation in USD adds ¥7.8B revenue and ¥1.7B core OP.
Explain SMT's impact on expenses.
Assess VYLOY's exceeding expectations.
Why impairment losses for Xyphos?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Astellas Pharma earnings date
Q2 202630 Oct, 2025
Next Astellas Pharma earnings date
Q2 202630 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Astellas Pharma Inc., is a Japanese multinational pharmaceutical company that emerged from the merger between Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. in 2005. Astellas focuses on several key therapeutic areas including oncology, urology, immunology, cardiology, and infectious diseases, with a priority on research and development in infectious diseases, diabetes, gastrointestinal diseases, oncology, and central nervous system diseases. Astellas Pharma Inc. is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage